Whitehawk Therapeutics Inc [NASDAQ: WHWK] surged by $0.04 during the normal trading session on previous day and reaching a high of $2.11 during the day while it closed the day at $2.05.
Whitehawk Therapeutics Inc stock has also gained 2.50% of its value over the past 7 days. However, WHWK stock has inclined by 1.49% in the 3 months of the year. Over the past six months meanwhile, it has lost -14.94% and lost -35.02% year-on date.
The market cap for WHWK stock reached $96.57 million, with 46.78 million shares outstanding and 26.18 million shares in the current float. Compared to the average trading volume of 134.32K shares, WHWK reached a trading volume of 110365 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Whitehawk Therapeutics Inc [WHWK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for WHWK shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on WHWK stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Whitehawk Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 27, 2024. The new note on the price target was released on August 21, 2024, representing the official price target for Whitehawk Therapeutics Inc stock. Previously, the target price had yet another drop from $11 to $1.50, while Jefferies kept a Hold rating on WHWK stock.
The Average True Range (ATR) for Whitehawk Therapeutics Inc is set at 0.14, with the Price to Sales ratio for WHWK stock in the period of the last 12 months amounting to 3.48. The Price to Book ratio for the last quarter was 0.43, with the Price to Cash per share for the same quarter was set at 4.90.
WHWK stock trade performance evaluation
Whitehawk Therapeutics Inc [WHWK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.50. With this latest performance, WHWK shares gained by 16.48% in over the last four-week period, additionally sinking by -14.94% over the last 6 months – not to mention a rise of 21.30% in the past year of trading.
Whitehawk Therapeutics Inc [WHWK]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Whitehawk Therapeutics Inc [WHWK] shares currently have an operating margin of -217.92% and a Gross Margin at 88.72%. Whitehawk Therapeutics Inc’s Net Margin is presently recorded at 99.42%.
Return on Equity for this stock inclined to 16.00%, with Return on Assets sitting at 16.00%.
Earnings per share (EPS) analysis for Whitehawk Therapeutics Inc [WHWK] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for WHWK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Whitehawk Therapeutics Inc go to 6.57%.
